Tennant FS, Rawson RA, Cohen A, Tarver A, Clabout C. Methadone plasma levels and persistent drug abuse in high dose maintenance patients. Subst Alcohol Actions Misuse 1983;4:369-74.

Tsuang MT , Lyons MJ, Eisen SA, Goldberg J, True W, Lin N, et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet 1996;67:473-7.


Vining E, Kosten TR, Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abuse . Br J Addict 1988;83:567-75.


Walsh SL, Gilson SF, Jasinski DR, Stapleton JM, Phillips RL, Dannals RF, et al. Buprenorphine reduces cerebral glucose metabolism in polydrug abusers. Neuropsychopharmacology 1994;10(3):157-70.


Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, et al. Am J Public Health 1991;81(9):1185-91.


Zweben JE, Payte JT. Methadone maintenance in the treatment of opioid dependence: a current perspective. West J Med 1990;152(5):588-99.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement